Trial Profile
Study of the Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 15 Oct 2012 Primary endpoint 'Viral-load' has been met, according to a Bristol-Myers Squibb media release.
- 15 Oct 2012 Primary endpoint 'Disease-recurrence' has been met, according to a Bristol-Myers Squibb media release.
- 15 Oct 2012 Efficacy results were reported in a Bristol-Myers Squibb media release.